Kevin Haas

Kevin Haas

Chief Tech/Sci/R&D Officer at VERACYTE, INC.

Net worth: 2 M $ as of 31/08/2026

40 year
Health Technology
Consumer Services
Commercial Services

Profile

Kevin R.
Haas
is currently an Advisor at Prime Movers Lab LLC since 2019 and Chief Technology & Development Officer at Veracyte, Inc. starting in 2026.
Formerly, Dr. Haas was Senior Director-Bioinformatics at Myriad Women's Health, Inc. from 2016 to 2018, Vice Chair & Board of Directors at USA Triathlon in 2021, Vice President at BioInformatics LLC, Advisor at Tempo Automation, Inc. from 2017 to 2019, and Senior Vice President-Engineering at Myriad Genetics, Inc. from 2019 to 2021.
Education includes an undergraduate degree from the University of Wisconsin in 2006 and a doctorate from the University of California, Berkeley in 2013.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/04/2026 44,221 ( 0.06% ) 2 M $ 31/08/2026
15/03/2026 1,80,022 ( 0.19% ) 579 671 $ 31/08/2026

Kevin Haas active positions

CompaniesPositionStart
VERACYTE, INC. Chief Tech/Sci/R&D Officer 24/03/2026
Consultant / Advisor 01/10/2019

Former positions of Kevin Haas

CompaniesPositionEnd
Director/Board Member 01/12/2021
Consultant / Advisor 01/09/2019
Corporate Officer/Principal 01/08/2018
Corporate Officer/Principal -
MYRIAD GENETICS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Kevin Haas's experience

Training of Kevin Haas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Technology Services

Finance

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!